Biotech · Private company · Ann Arbor, MI, US
BlueWillow Biologics
Track this companyFree. Adds BlueWillow Biologics to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- BW-1010: 100 µg - pipette - INPhase 1 · AnthraxClinicalTrials.gov · fetched Nov 12, 2026
- BW-1010: 100 µg - sprayer - INPhase 1 · AnthraxClinicalTrials.gov · fetched Nov 12, 2026
- BW-1010: 50 µg - pipette - INPhase 1 · AnthraxClinicalTrials.gov · fetched Nov 12, 2026
- BW-1010: 50 µg - sprayer - INPhase 1 · AnthraxClinicalTrials.gov · fetched Nov 12, 2026
- BW-1014: 100 µg rH5 in 20% NE - pipette - INPhase 1 · Influenza, PandemicClinicalTrials.gov · fetched Nov 12, 2026
- BW-1014: 25 µg rH5 in 20% NE - pipette - INPhase 1 · Influenza, PandemicClinicalTrials.gov · fetched Nov 12, 2026
- BW-1014: 50 µg rH5 in 20% NE - pipette - INPhase 1 · Influenza, PandemicClinicalTrials.gov · fetched Nov 12, 2026
- H5N1 IIV - IMPhase 1 · Influenza, PandemicClinicalTrials.gov · fetched Nov 12, 2026
- rH5 (100 µg) control - pipette - INPhase 1 · Influenza, PandemicClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy AdultsPHASE1 · COMPLETED · started Jul 7, 2022ClinicalTrials.gov NCT05397119 · fetched Nov 12, 2026
- A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Anthrax Vaccine in Healthy AdultsPHASE1 · COMPLETED · started Jan 8, 2020ClinicalTrials.gov NCT04148118 · fetched Nov 12, 2026
NIH awards1
- Development of a Mucosal Nanoemulsion-Adjuvanted RSV Vaccine using Recombinant Pre-Fusion F ProteinFiscal year 2024 · $891.7KNIH RePORTER 5R44AI145431-04 · fetched Nov 12, 2026